Filter
1622
Filtered Results: 1622
Text search:
protein-based
Featured
Recommendations
210
New Publications
470
Language
Document type
No document type
905
Guidelines
298
Studies & Reports
212
Manuals
90
Fact sheets
43
Training Material
35
Strategic & Response Plan
21
Brochures
5
Situation Updates
5
Resource Platforms
3
Infographics
3
Videos
2
Countries / Regions
India
129
Kenya
51
Global
49
South Africa
38
Nepal
31
Ethiopia
30
Uganda
29
Nigeria
28
Tanzania
27
Sierra Leone
22
Rwanda
22
Indonesia
22
Philippines
19
Africa
19
Bangladesh
19
Liberia
18
Latin America and the Carribbean
17
Namibia
17
Senegal
16
Malawi
16
Zambia
16
Myanmar / Burma
15
Ghana
14
Russia
14
West and Central Africa
13
Western and Central Europe
12
East and Southern Africa
12
Brazil
11
Lesotho
10
Venezuela
10
Syria
9
Congo, Democratic Republic of
9
South Sudan
9
Ukraine
8
Germany
8
Middle East and North Africa
8
Mozambique
7
South–East Asia Region
7
Eastern Europe
7
Eswatini/ Swaziland
7
Zimbabwe
6
USA
6
Yemen
6
Colombia
5
Cameroon
5
Guinea
5
Madagascar
5
Chile
4
Haiti
4
Asia
4
Sudan
4
Botswana
4
Somalia
4
Benin
3
Burkina Faso
3
Afghanistan
3
Peru
3
Cambodia
3
Western Pacific Region
3
Papua New Guinea
3
Mali
3
Libya
3
Iraq
3
Ecuador
3
Pakistan
3
Mexico
2
Togo
2
Iran
2
Niger
2
Qatar
2
Italy
2
Jordan
2
Saudi Arabia
2
Eastern Europe and Central Asia
2
France
2
Spain
2
Lebanon
2
Egypt
2
Angola
2
Tajikistan
1
El Salvador
1
Gambia
1
China
1
Kazakhstan
1
Albania
1
Singapore
1
Congo-Brazzaville
1
Morocco
1
Mongolia
1
Mauritania
1
Dominican Republic
1
Paraguay
1
Jamaica
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Latvia
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Nicaragua
1
Moldova
1
Djibouti
1
Palestine
1
Central African Republic
1
Honduras
1
Chad
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
628
Clinical Guidelines
243
Women & Child Health
110
Public Health
104
Key Resources
61
Pharmacy & Technologies
40
Capacity Building
38
Toolboxes
COVID-19
166
TB
107
HIV
72
Planetary Health
71
Mental Health
58
NCDs
53
NTDs
52
AMR
52
Caregiver
48
Rapid Response
47
Ebola
43
Pharmacy
31
Conflict
31
Refugee
23
Global Health Education
16
Polio
10
Natural Hazards
8
Disability
7
Cholera
7
Zika
7
Specific Hazards
6
Health Financing Toolbox
3
Typhoon
1
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
Diets are changing everywhere, and the burden of disease associated with unhealthy diets is a worldwide concern. Measurement and monitoring of diets across countries and population groups is critical. However, there are no harmonized metrics for tracking how the healthfulness of diets around the wor...
This guideline provides updated, evidence-informed guidance on the percentage of total fat in the diet to reduce the risk of unhealthy weight gain.
This guideline is intended for a wide audience involved in the development, design and implementation of policies and programmes in nutrition and pub...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the key information needed for advising their Member States in response to questions raised on human health due to influenza outbreaks or detections in...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
A global Pandemic, Preparedness and Response (RRR) architecture
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
To survive and thrive, children and adolescents need good health, adequate nutrition, security, safety and a supportive clean environment, opportunities for early learning and education, responsive relationships and connectedness, and opportunities for personal autonomy and self-realization. To prom...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South
American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention
and rehabilitation (CVDPR). In the context of the imple...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was...
The document provides detailed clinical guidelines for the therapy of Type 1 Diabetes as developed by the German Diabetes Association (DDG). It focuses on individualized insulin therapy, structured patient training, and monitoring of blood glucose levels. The guidelines emphasize preventing complica...
